Opportunity

Simpler Grants.gov #PAR-25-014

FDA Cooperative Agreement for Antibiotic Resistance Surveillance in Retail Food

Buyer

Food and Drug Administration

Posted

July 11, 2025

Respond By

April 01, 2027

Identifier

PAR-25-014

NAICS

541715

The Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), is seeking partners for a cooperative agreement to enhance antibiotic resistance surveillance in retail food specimens under the National Antimicrobial Resistance Monitoring System (NARMS): - Government Buyer: - Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM) - Program Purpose: - Support and expand surveillance of antibiotic resistance in bacteria found in retail food commodities - Improve detection capabilities and broaden the number of sampling sites - Funding Details: - Cooperative agreement with a maximum award of $200,000 per recipient - Total program funding of $5,000,000 - Eligibility: - Open to higher education institutions, nonprofits, for-profit organizations, and various government entities - Products/Services Requested: - No specific products or OEMs required; focus is on surveillance activities and programmatic support - Notable Requirements: - Activities must align with NARMS objectives to protect public health by combating antibiotic resistance threats - Emphasis on expanding sampling and improving detection in food surveillance - No OEMs or commercial vendors are specified, as this is a grant for public health surveillance, not a product procurement.

Description

This Funding Opportunity Announcement (FOA) by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), aims to enhance and sustain antibiotic resistance surveillance in retail food specimens within the National Antimicrobial Resistance Monitoring System (NARMS) program. The cooperative agreement seeks to improve detection of antibiotic resistance among bacteria in food commodities and expand sampling sites. The program's measurable outcomes will align with the NARMS Objectives. The funding supports public health protection by combating antibiotic resistance threats.

View original listing